AKT1 and cancer: It is estimated that at least 50% of all cancer patients and 60% of all PDAC patients have deregulation of the PI3K/Akt signaling pathway (Bondar et al., 2002; Schlieman et al., 2003; Yuan and Cantley, 2008; Schild et al., 2009).